Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.

Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

Abstract

Rationale Agonist-based pharmacologic intervention is an accepted approach in treatment of opioid and tobacco use disorders.Objectives We conducted a systematic review and meta-analysis to evaluate usefulness of an agonist approach as treatment of (psycho)stimulant use disorder (PSUD).Methods We reviewed PubMed/Medline, LILACS, and ClinicalTrials.gov databases searching for randomized, double-blind, placebo-controlled, parallel-design studies evaluating outcomes of individuals treated for cocaine- or amphetamine-type substance use disorder. We combined results of all trials that included the following prescription psychostimulants (PPs): modafinil, methylphenidate, or amphetamines (mixed amphetamine salts, lisdexamphetamine, and dextroamphetamine). The combined sample consisted of 2889 patients. Outcomes of interest included the following: drug abstinence (defined as 2-3 weeks of sustained abstinence and the average maximum days of consecutive abstinence), percentage of drug-negative urine tests across trial, and retention in treatment. We conducted random-effects meta-analyses and assessed quality of evidence using the GRADE system.Results Thirty-eight trials were included. Treatment with PPs increases rates of sustained abstinence [risk ratio (RR) = 1.45, 95% confidence interval (CI) = (1.10, 1.92)] and duration of abstinence [mean difference (MD) = 3.34, 95% CI = (1.06, 5.62)] in patients with PSUD, particularly those with cocaine use disorder (very low-quality evidence). Prescription amphetamines were particularly efficacious in promoting sustained abstinence in patients with cocaine use disorder [RR = 2.44, 95% CI = (1.66, 3.58)], and higher doses of PPs were particularly efficacious for treatment of cocaine use disorder [RR = 1.95, 95% CI = (1.38, 2.77)] (moderate-quality evidence). Treatment with prescription amphetamines also yielded more cocaine-negative urines [MD = 8.37%, 95% CI = (3.75, 12.98)]. There was no effect of PPs on the retention in treatment.Conclusion Prescription psychostimulants, particularly prescription amphetamines given in robust doses, have a clinically significant beneficial effect to promote abstinence in the treatment of individuals with PSUD, specifically the population with cocaine use disorder.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-020-05563-3

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 118 references

Research works printed but not linked: 2

  1. Grabowski J, Schmitz J, Roache J, Rhoades H, Elk R, Creson D (1994) Methylphenidate (MP) for initial treatment of cocaine dependence and a model for medication evaluation. NIDA Research Monograph 141:436–436
  2. The Nordic Cochrane Centre TCC (2014) Review Manager (RevMan) [Computer program] Version 5.3

Cited by

See all 151

Metadata

Authors
Tardelli, V. S., Bisaga, A., Arcadepani, F. B., Gerra, G., Levin, F. R., & Fidalgo, T. M.
Affiliations
  • Universidade Federal de São Paulo (BR)
  • New York State Psychiatric Institute (US)
  • United Nations Office on Drugs and Crime (AT)
Corresponding author
Tardelli, Vitor S.
Venue
Psychopharmacology
Published
2020-06-29
Volume
237
Issue
8
Pages
2233-2255
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W3038588160
Cited by
151
References
118
Citations by year
2026: 19 · 2025: 28 · 2024: 26 · 2023: 34 · 2022: 19 · 2021: 17 · 2020: 8
FWCI
2.84
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Keywords
stimulant use disorder, cocaine dependence, amphetamine use disorder, modafinil, methylphenidate, mixed amphetamine salts, d-amphetamine, sustained abstinence, treatment retention, urine drug testing, dose-response relationship, safety and tolerability, relapse
MeSH terms
Lisdexamfetamine Dimesylate, Modafinil, Amphetamine, Central Nervous System Stimulants, Cocaine, Double-Blind Method, Humans, Methylphenidate, Randomized Controlled Trials as Topic, Treatment Outcome, Substance-Related Disorders, Prescription Drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s00213-020-05563-3
The paper
Tardelli, V. S., Bisaga, A., Arcadepani, F. B., Gerra, G., Levin, F. R., & Fidalgo, T. M. (2020). Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology. https://doi.org/10.1007/s00213-020-05563-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.